Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/06/1996 | CA2205577A1 Hindered n-oxide esters of rapamycin and their use as medicaments |
06/06/1996 | CA2204902A1 Phosphocholine drug derivatives |
06/06/1996 | CA2204000A1 Enantioselective preparation of pharmaceutically active sulfoxides by bioreduction |
06/06/1996 | CA2203999A1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation |
06/06/1996 | CA2180745A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof |
06/06/1996 | CA2164375A1 Heterocyclic amides |
06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
06/05/1996 | EP0714908A2 New 17-(3-imino-2-alkyl-propenyl)-5beta,14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
06/05/1996 | EP0714907A1 Oligoribonucleotides with amide backbone |
06/05/1996 | EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors |
06/05/1996 | EP0714897A1 Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity |
06/05/1996 | EP0714896A1 Indol derivatives useful for the treatment of migraine, composition and utilization |
06/05/1996 | EP0714895A1 Pyrrole derivatives |
06/05/1996 | EP0714894A1 3-(1,2,3,6-tetrahydro-(1-alkylenearyl)-4-pyridinyl)- and 3-(1-alkylenearyl)-4-piperidinyl-1h-indoles: new 5-HT1f agonists |
06/05/1996 | EP0714883A1 Aryloxypropanolamine beta 3 adrenergic agonists |
06/05/1996 | EP0714880A1 Bis(methylidene)-phenylene-derivatives |
06/05/1996 | EP0714663A2 Potentiation of drug response by a serotonin 1A receptor antagonist |
06/05/1996 | EP0714661A1 Process for the preparation of tablets containing molsidomine |
06/05/1996 | EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles |
06/05/1996 | EP0714659A2 Indole derivatives in the treatment of emesis |
06/05/1996 | EP0714658A1 Apoptosis inducer |
06/05/1996 | EP0714449A1 Oligonucleotide modulation of protein kinase c |
06/05/1996 | EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
06/05/1996 | EP0714436A1 Oligonucleotides with activity against human immunodeficiency virus |
06/05/1996 | EP0714418A1 Cosmetic melanins |
06/05/1996 | EP0714411A1 Bioadhesive starches and process for their preparation |
06/05/1996 | EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
06/05/1996 | EP0714397A1 Phenethylamine compounds |
06/05/1996 | EP0714396A1 Vasocontrictive dihydrobenzopyran derivatives |
06/05/1996 | EP0714395A1 Vasoconstrictive substituted dihydropyranopyridines |
06/05/1996 | EP0714394A1 Antipsychotic method |
06/05/1996 | EP0714393A1 Thiazoles as antiviral |
06/05/1996 | EP0714392A1 Heterocycles useful as neurokinin antagonists |
06/05/1996 | EP0714391A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
06/05/1996 | EP0714390A1 Indole derivatives as 5-alpha-reductase-1-inhibitors |
06/05/1996 | EP0714389A1 Amide and urea derivatives as 5ht1d receptor antagonists |
06/05/1996 | EP0714388A1 Vasoconstrictive substituted aryloxyalkyl diamines |
06/05/1996 | EP0714387A1 New bis-naphthalimides for the treatment of cancer |
06/05/1996 | EP0714386A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations |
06/05/1996 | EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides |
06/05/1996 | EP0714304A1 Therapeutic system for treating psoriasis |
06/05/1996 | EP0714303A1 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents |
06/05/1996 | EP0714301A1 Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments |
06/05/1996 | EP0714300A1 Methods for modulating the human sexual response |
06/05/1996 | EP0714299A1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
06/05/1996 | EP0714298A1 Photosensitizers |
06/05/1996 | EP0714297A1 Novel 1,2-dithiin antiinfective agents |
06/05/1996 | EP0714296A1 Flavonoid and biflavonoid derivatives, their pharmaceutical compositions, their anxiolytic activity |
06/05/1996 | EP0714295A1 Fibrinogen receptor antagonists |
06/05/1996 | EP0714294A1 Pharmaceutical compositions comprising metal complexes |
06/05/1996 | EP0714293A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates |
06/05/1996 | EP0714291A1 Lupane triterpenoid derivatives |
06/05/1996 | EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
06/05/1996 | EP0714284A1 Use of oligosaccharides for the prevention and treatment of tissue ageing |
06/05/1996 | EP0633780B1 Use of phenothiazine derivatives for treating ischaemia and/or hypoxia |
06/05/1996 | EP0569383B1 LOW-MOLECULAR SULPHATED POLY-$g(b)-2,6-FRUCTOFURANOSANES AND THEIR USE IN THE TREATMENT OF DEGENERATIVE ARTICULAR AILMENTS |
06/05/1996 | EP0555229B1 Accumulation of amino acids and peptides into liposomes |
06/05/1996 | EP0460169B1 New chroman and thiochroman derivatives |
06/05/1996 | EP0450039B1 Dihydro-1,2 oxo-2 quinoxaline derivates, their preparation and their application in therapeutics |
06/05/1996 | DE4442999A1 Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten A pharmaceutical composition comprising an active loratidine metabolite |
06/05/1996 | DE4442987A1 Kationische Biopolymere Cationic biopolymers |
06/05/1996 | DE4442975A1 Agent contg. inulin for treating diabetes |
06/05/1996 | DE4442766A1 Agent for treating arterial disorders and prostate complaints |
06/05/1996 | DE4442561A1 Use of sucking pastilles contg. dimethicone |
06/05/1996 | DE19501022C1 Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung Transdermal therapeutic system for administration of (S) -3-methyl-5- (1-methyl-2-pyrrolidenyl) isoxazole or a pharmaceutically acceptable salt thereof and process for its preparation |
06/05/1996 | CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy |
06/05/1996 | CN1124027A Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
06/05/1996 | CN1124026A Thioindole pyperidinyl derivatives used as antalgics |
06/05/1996 | CN1124012A Arylating medicaments |
06/05/1996 | CN1124006A Cholesterol lowering drink mix compositions |
06/05/1996 | CN1123793A Non-reducing oligosaccharide and its production and use |
06/05/1996 | CN1123664A Veterinary injection and its production |
06/05/1996 | CN1123663A Composition for curing angicardiopathy and its production and usage |
06/05/1996 | CN1123662A Special chicken-disease injection and its production |
06/05/1996 | CN1123661A Zhonghua Lixing injection for dysentery and its production |
06/05/1996 | CN1031942C Process for preparing steroids containing spiro ring use as pharmaceutical |
06/05/1996 | CN1031940C Process for preparing substituted pyrrole compounds |
06/05/1996 | CN1031939C Preparing process for brufen by molecular rearrangement under catalysis |
06/04/1996 | US5523492 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
06/04/1996 | US5523490 Antitumor agents |
06/04/1996 | US5523475 2-nitro-3-hydroxybenzoic acids as enzyme inhibitors of 3-hydroxyanthranilate oxygenase active in producing the neurotoxin, quinolinic acid |
06/04/1996 | US5523464 Bone disorders |
06/04/1996 | US5523461 Stabilization of a prostanoic acid compound |
06/04/1996 | US5523457 Used for preventing or treating skin disorders like acne, psoriasis, damage for irradiation; antitumor agent |
06/04/1996 | US5523455 Prepared using a naphthylhydrazine chemical intermediate |
06/04/1996 | US5523415 Bactericides |
06/04/1996 | US5523407 Quinoline derivatives, their production and use as ACAT inhibitors |
06/04/1996 | US5523406 2-substituted tertiary carbinol derivatives of 1,5-iminosugars |
06/04/1996 | US5523403 Tropone-substituted phenyloxazolidinone antibacterial agents |
06/04/1996 | US5523389 Inhibitors of human immunodeficiency virus |
06/04/1996 | US5523324 Composition |
06/04/1996 | US5523323 Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence |
06/04/1996 | US5523322 Method for inhibiting blood-platelet aggregration with β-naphthoquinone compounds |
06/04/1996 | US5523321 Prostacyclins, their analogs or prostaglandins and thromboxane antagonists for treatment of thrombotic and thromboembolic syndromes |
06/04/1996 | US5523320 For treatment of leukemia |
06/04/1996 | US5523319 Compounds of the benzo-heterocycle family |
06/04/1996 | US5523318 Pyrrolidino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
06/04/1996 | US5523317 Administering imidazole derivative |
06/04/1996 | US5523315 N-(hydroxyethyl)butanediamide derivatives |
06/04/1996 | US5523314 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |